Aviatrix Automates Cloud Networking Within AWS Control Tower to Ensure Organizations Have a ‘Well-Architected’ Network Topology
Aviatrix, the cloud network platform, today announced new capabilities to automate enterprise network infrastructure deployment and operations for organizations using the account factory feature of AWS Control Tower. Available now in AWS Marketplace, the integrated Aviatrix software serves as the network factory for newly provisioned accounts on Amazon Web Services (AWS). The solution helps enterprise organizations meet cloud governance and regulatory initiatives for their multi-account, multi-region cloud networks.
Join experts from Aviatrix and AWS on Thursday, August 27th as they host a live, online session to highlight the new AWS Control Tower and Aviatrix network factory capabilities. For more information or to register, go here.
“With AWS Control Tower, it only takes a few clicks for enterprise organizations to provision new AWS accounts that conform to company-wide policies,” said Chris Grusz, Director, AWS Marketplace, Amazon Web Services, Inc. “The Aviatrix cloud networking solution uniquely offers a network factory for AWS Control Tower. With AWS Control Tower account factory ensuring account control governance, customers will benefit from Aviatrix’s new capabilities that make certain the network infrastructure supporting those accounts is secure and correctly deployed every time.”
AWS Control Tower provides the easiest way to set up and govern new, secure, multi-account AWS environments. Additionally, AWS Service Catalog enables organizations to create and manage catalogs of approved IT services for use on AWS. The Aviatrix cloud network platform provides the prescriptive transit network architecture and operational visibility that meets enterprise cloud networking and security requirements. The Aviatrix software is able to create Amazon Virtual Private Clouds (Amazon VPCs), automate route table updates and ensure network correctness by preventing overlapping CIDRs, while also enforcing IT security controls through policy-based network segmentation. The integrated solution enables self-service delivery of new account infrastructure, provides detailed operational visibility, and helps ensure IT networking and security teams achieve compliance through a simple, automated workflow.
“In the journey to leverage cloud-based infrastructure we are always on the lookout for ways to streamline the automated delivery of services, in the simplest, most secure manner,” said Justin Donohoo, CTO at Observian. “The Aviatrix cloud network platform delivers the network architecture, advanced network, security controls, and operational visibility enterprises need. I view the integration of Aviatrix with AWS Control Tower as a natural evolution to streamline the delivery of new AWS infrastructure. Leveraging Aviatrix as the network factory and the AWS Control Tower account factory ensures that both AWS accounts and enterprise network infrastructure are deployed correctly and in compliance with corporate policies and industry regulations.”
Provisioning cloud network services is often easier than operationalizing them. AWS Control Tower customers who need to be in full control of their cloud network environment can also use the Aviatrix software to access the network intelligence they need – all in one place – instead of logging into multiple screens, services and management consoles to stitch together the network visibility they require. Aviatrix CoPilot – an available component of the integrated solution for AWS Control Tower - provides a global view of the cloud environment by leveraging intelligence and analytics from the Aviatrix cloud network platform combined with telemetry and network information gathered using native AWS APIs. CoPilot’s rich, intuitive visualizations provide actionable insights to practitioners by using dynamic multi-cloud topology maps, FlowIQ intelligent traffic flow analytics, global traffic heat maps, time series trend charts and a complete cloud network monitoring dashboard.
“AWS Control Tower is a leap forward for enterprise IT teams who are tasked with maintaining control over their networks, without becoming a bottleneck to their organization’s cloud agility and speed,” said Nauman Mustafa, VP of Solution Engineering at Aviatrix. “Regulatory compliance and corporate governance must be automated and adopted for the cloud era. The combination of AWS Control Tower and Aviatrix cloud network platform delivers the simplicity and automation along with enterprise visibility and control.”
Availability and How to Get Started
Aviatrix cloud network platform for AWS Control Tower is available immediately in AWS Marketplace. More technical information on the integrated solution - including how to get started - is available here. For a live demo or further information, please email info@aviatrix.com
About Aviatrix
Aviatrix cloud network platform delivers advanced networking, security and operational visibility required by enterprises with the simplicity and automation of cloud. More than 400 customers worldwide leverage Aviatrix and its proven multi-cloud network reference architecture to design, deploy and operate a repeatable network and security architecture that is consistent across any public cloud. Combined with the industry’s first and only multi-cloud networking certification (ACE), Aviatrix is empowering IT to lead and accelerate the transformation to the cloud. Learn more at Aviatrix.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200825005365/en/
Contact information
Aviatrix
Frank Cabri
frank@aviatrix.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 10:00:00 EET | Press release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 09:44:00 EET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 09:42:00 EET | Press release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 09:30:00 EET | Press release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 04:06:00 EET | Press release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom